You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
亞寶藥業(600351.SH)取得特殊醫學用途配方食品註冊證書
格隆匯 05-28 18:06

格隆匯5月28日丨亞寶藥業(600351.SH)公佈,2020年5月28日,公司收到國家市場督管理總局核准簽發的《特殊醫學用途配方食品註冊證書》。

特殊醫學用途配方食品是為了滿足進食受限、消化吸收障礙、代謝紊亂或特定疾病狀態人羣對營養素或膳食的特殊需要,專門加工配製而成的配方食品。該類產品須在醫生或者臨牀營養師指導下,單獨食用或與其他食品配合食用。特醫食品能夠糾正人體代謝失衡、減少感染等併發症、增強各種治療手段的效果、促進病人康復、改善病人生活質量和減少醫療費用等多種功效。

據中國營養保健食品協會統計,全球每年特醫食品的消費總額為560億元-640億元,市場規模以每年6%的速度遞增;目前我國特醫食品市場規模約佔全球的1%,總量約為6億元,但發展勢頭迅猛,年平均增速超過30%。

公司本產品註冊申請的受理時間為2019年4月2日(受理號:國食注申TY20190029)。目前,除公司外,國內取得特醫食品註冊證書共計50個,適用於10歲以上人羣的特醫全營養配方食品註冊證書共計11個。

截止目前,公司在該產品已累計投入研發費用約為142萬元人民幣。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account